FDA Approved Drug with New Mechanism of Action for Treatment of Schizophrenia
On Sept. 26, 2024, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers Squibb’s Cobenfy (xanomeline and trospium…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
CIRM Awarded $67.5 Million to Address Neuropsychiatric Diseases
On Aug. 30, 2024, the California Institute for Regenerative Medicine (CIRM) approved $67.5 million to support five projects…
The Allen Institute for Brain Science Completed the Brain Atlas
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
FDA approved Risperidone for use as atypical antipsychotic medication
On Dec. 29, 1993, the U.S. Food and Drug Administration (FDA) approved indications for oral risperidone (tablets, oral…
Autism appeared for the first time as a diagnosis in the third edition of the DSM III Diagnostic and Statistical Manual of Mental Disorders
In 1980, autism appeared for the first time as a diagnosis in the third edition of the DSM…
The first edition of “Diagnostic and Statistical Manual of Mental Disorders” mentioned autism to describe symptoms of schizophrenia before puberty
In 1952, the first edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) was published and…
Swiss psychiatrist Eugen Bleuler coined the term ‘schizophrenia’
On Apr. 24, 1908, Swiss psychiatrist Eugen Bleuler coined the term ‘schizophrenia’ at a lecture at a meeting…